<p>Shown is a typical tissue sub-model component of the PBPK model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0017874#pone.0017874-Ferl1" target="_blank">[13]</a> used to assess the influence of parameter variability among literature and measured <i>V<sub>v</sub></i>, <i>V<sub>i</sub></i> and <i>Q</i> values on tissue uptake of an IgG (expressed as AUC<sub>0–7</sub>). Antibody enters tissue from the central plasma compartment via arterial blood flow where it continues to the lungs via venous blood flow or returns directly to the central plasma compartment through the lymphatic system subsequent to extravasation into interstitial space. The AUC<sub>0–7</sub> values listed in <a href="http://www.plosone.org/article/...
Immune checkpoint blockades prescribed in the neoadjuvant setting are now under active investigation...
In our companion paper, we described the theoretical basis for tissue lumping in whole-body physiolo...
Minimal physiologically based pharmacokinetic (mPBPK) models, consisting of system-specific (e.g., t...
<p>The tissue is divided into vascular, interstitial, and cellular compartments (depicted in red, gr...
For most therapeutic antibodies, the interstitium is the target space. Although experimental methods...
bioavailability to organs protected by biological barriers Nadia Quignot1,2 Computational pharmacoki...
Advances in antibody engineering have enabled the construction of novel molecular formats in diverse...
This record contains an article, several datasets, an OpenGL Shader Builder Project (sbproj) file, a...
Physiologically-based pharmacokinetic (PBPK) modeling is a mathematical tool to assess the adsorptio...
The identification of clinically meaningful and predictive models of disposition kinetics for cancer...
<p>(A) The concentration of each imaging agents in blood was measured by fluorescence, and plotted a...
Antibodies are under development to treat a variety of cancers, such as lymphomas, colon, and breast...
Summary and comments ("Research Highlights" in News and Views of the journal "Biomarkers in Medicine...
To predict the drug hemeatic levels after administration is a goal of great interest in the design o...
BACKGROUND: The identification of clinically meaningful and predictive models of disposition kinetic...
Immune checkpoint blockades prescribed in the neoadjuvant setting are now under active investigation...
In our companion paper, we described the theoretical basis for tissue lumping in whole-body physiolo...
Minimal physiologically based pharmacokinetic (mPBPK) models, consisting of system-specific (e.g., t...
<p>The tissue is divided into vascular, interstitial, and cellular compartments (depicted in red, gr...
For most therapeutic antibodies, the interstitium is the target space. Although experimental methods...
bioavailability to organs protected by biological barriers Nadia Quignot1,2 Computational pharmacoki...
Advances in antibody engineering have enabled the construction of novel molecular formats in diverse...
This record contains an article, several datasets, an OpenGL Shader Builder Project (sbproj) file, a...
Physiologically-based pharmacokinetic (PBPK) modeling is a mathematical tool to assess the adsorptio...
The identification of clinically meaningful and predictive models of disposition kinetics for cancer...
<p>(A) The concentration of each imaging agents in blood was measured by fluorescence, and plotted a...
Antibodies are under development to treat a variety of cancers, such as lymphomas, colon, and breast...
Summary and comments ("Research Highlights" in News and Views of the journal "Biomarkers in Medicine...
To predict the drug hemeatic levels after administration is a goal of great interest in the design o...
BACKGROUND: The identification of clinically meaningful and predictive models of disposition kinetic...
Immune checkpoint blockades prescribed in the neoadjuvant setting are now under active investigation...
In our companion paper, we described the theoretical basis for tissue lumping in whole-body physiolo...
Minimal physiologically based pharmacokinetic (mPBPK) models, consisting of system-specific (e.g., t...